Published: 8 December 2016

Recent Approvals of Medicines containing a New Active Ingredient

Prescriber Update 37(4): 58
December 2016

For period 16 July to 15 October 2016

TradeName (Active ingredient) Dose form and strength Therapeutic area
Cyramza (ramucirumab) Concentrate for infusion
100 mg/10 mL and 50 mg/50 mL
Advanced or metastatic gastric or gastro- oesophageal junction adenocarcinoma
Sirturo (bedaquiline) Tablet 100 mg Multi-drug resistant tuberculosis

The data sheets for currently marketed prescription medicines are published on the Medsafe website (